PHRM PharmaTher Holdings Ltd.

CNQ · CA · Healthcare · Biotechnology · pharmather.com

0.0550CAD+10.00%Mkt Cap: 3.65M $P/E: —3d ago

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's …

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

Genmab A/S - American Depositary Shares

$21.69BUSDP/E 27.4

JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap3.65M USD

Enterprise Value2.97M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-444.56K USD

Revenue/Share—

Last Price0.0550 CAD

Fiscal Year EndMay 2026

MR QuarterMay 2026

Employees—

CountryCA

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.50

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B9.17

EPS (TTM)-0.02

EPS (Forward)-0.11

52W Range

0.04502% of range0.4500

52W High0.4500 CAD

52W Low0.0450 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-76.95%

ROA-39.49%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-353.21K USD

CapEx (TTM)—

FCF Margin—

FCF Yield-6.70%

Net Debt-671.12K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio1.82

Quick Ratio1.82

Book Value/Sh0.0060 CAD

Cash/Share0.01 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.91.02M

Float73.51M

Insiders18.74%

Institutions0.00%

Short Interest

Short Ratio0.3d

Short % Out.0.01%

Shares Short13.62K

Short (prev mo.)11.81K

Technical

SMA 500.0550 (-0.0%)

SMA 2000.0701 (-21.5%)

Beta2.34

S&P 52W Chg14.58%

Avg Vol (30d)68.13K

Avg Vol (10d)53.25K

Technical Indicators

RSI (14)50.8

MACD-0.0006

MACD Signal-0.0005

MACD Hist.-0.0001

BB Upper0.0635 CAD

BB Middle0.0553 CAD

BB Lower0.0470 CAD

BB Width29.89%

ATR (14)0.0043 CAD

Vol Ratio (20d)2.86x